Neoplastic meningitis from breast cancer has a dismal prognosis and short survival. Treatment is based on the intrathecal administration of chemotherapeutic agents, cranial or craniospinal radiotherapy, and systemic chemotherapy. In this report we describe the case of a woman with neoplastic meningitis from breast carcinoma who developed an excellent response to letrozole combined with intrathecal methotrexate, resulting in long-term survival of more than 36 months. Based on the findings of this case report, we suggest that addition of letrozole to the standard therapeutic approach may be beneficial for some patients.
Neoplastic meningitis Breast carcinoma Letrozole Methotrexate Cerebrospinal fluid
This is a preview of subscription content, log in to check access.
Moots P, Harrison M, Vandenberg S (1995) Prolonged survival in carcinomatous meningitis associated with breast cancer. South Med J 88:357–362PubMedGoogle Scholar
Boogerd W, Bent MJ, Koehler PJ et al (2004) The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomized study. Eur J Cancer 40:2726–2733CrossRefPubMedGoogle Scholar
Boogerd W, Dorresteijn LD, van Der Sande JJ, de Gast GC, Bruning PF (2000) Response of leptomeningeal metastases from breast cancer to hormonal therapy. Neurology 12:117–119Google Scholar
Ozdogan M, Samur M, Bozcuk H et al (2003) Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection. Jpn J Clin Oncol 33:229–231CrossRefPubMedGoogle Scholar
Jayson G, Howell A (1996) Carcinomatous meningitis in solid tumors. Ann Oncol 7:773–786PubMedGoogle Scholar
Garcia-Casado Z, Guerrero-Zotano A, Llombart-Cussac A et al (2010) A polymorphism at the 3′-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole. BMC Cancer 10:36CrossRefPubMedGoogle Scholar
Neville-Webbe HL, Coleman RE, Holen I (2010) Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction. Br J Cancer 102:1010–1017CrossRefPubMedGoogle Scholar
Lien EA, Wester K, Lonning PE, Solheim E, Ueland PM (1991) Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast cancer patients. Br J Cancer 63:641–645CrossRefPubMedGoogle Scholar
Madhup R, Kirti S, Bhatt MLB et al (2006) Letrozole for brain and scalp metastases from breast cancer—a case report. The Breast 15:440–442CrossRefPubMedGoogle Scholar